M Jensterle
Overview
Explore the profile of M Jensterle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Poredos P, Schernthaner G, Blinc A, Mikhailidis D, Jensterle M, Anagnostis P, et al.
Curr Vasc Pharmacol
. 2023 Dec;
22(4):236-241.
PMID: 38038006
Cushing syndrome (CS), characterised by endogenous or exogenous glucocorticoid hormone excess, is associated with several systemic complications, including impaired glucose metabolism, which often becomes clinically manifest as diabetes mellitus (DM)....
2.
Herman R, Janez A, Mikhailidis D, Poredos P, Blinc A, Sabovic M, et al.
Curr Vasc Pharmacol
. 2023 Nov;
22(1):28-35.
PMID: 37962050
Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) are increasingly recognised for their role in cardiovascular (CV) physiology. The GH-IGF-1 axis plays an essential role in the development of...
3.
Abdulkhalikova D, Sustarsic A, Vrtacnik Bokal E, Jancar N, Jensterle M, Burnik Papler T
Front Endocrinol (Lausanne)
. 2022 Jul;
13:888460.
PMID: 35813634
Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT04989244?term=NCT04989244&draw=2&rank=1, identifier: NCT04989244.
4.
Jensterle M, Podbregar A, Goricar K, Gregoric N, Janez A
Endocr Connect
. 2019 Feb;
8(3):195-202.
PMID: 30707677
Lifestyle measures (LSMs) should be the first-line approach offered for obesity-related functional hypogonadism (FH). When LSMs fail, the role of testosterone replacement treatment (TRT) is unclear. GLP1 receptor agonist liraglutide...
5.
Vrtovec B, Meden-Vrtovec H, Jensterle M, Radovancevic B
J Endocrinol Invest
. 2008 Sep;
31(7):653-5.
PMID: 18787386
Context: The presence of several cardiovascular risk factors is observed in women with polycystic ovary syndrome (PCOS). On the other hand, the QTc interval duration, which is related to cardiac...
6.
Poredos P, Golob M, Jensterle M
Int Angiol
. 2003 May;
22(1):83-7.
PMID: 12771862
Aim: Atherosclerosis is considered a systemic disease. Therefore, in patients with atherosclerotic disease effects on various sections of the arterial system are expected. The aim of our study was to...